Pyrexia, commonly known as fever, is a prevalent symptom in various clinical scenarios. It is a complex physiological response to disease, often indicating the presence of infection or inflammation. This article provides a comprehensive guide to understanding and managing pyrexia in clinical practice.
Pyrexia is a result of an altered hypothalamic set point, making the body perceive a normal temperature as suboptimal. This change is usually triggered by pyrogens, substances produced by infectious agents or released by immune cells. The body responds by increasing heat production and reducing heat loss, leading to an elevated body temperature.
Initial assessment should focus on identifying potential sources of infection or inflammation. A detailed history, physical examination, and targeted investigations are crucial. The pattern of fever can provide valuable clues. For instance, intermittent high-grade fever is characteristic of sepsis, while a low-grade fever that worsens in the evening is often seen in tuberculosis.
Management should be directed towards the underlying cause. In infectious causes, appropriate antimicrobial therapy is essential. Fever itself can be managed with antipyretics like paracetamol. However, fever is a physiological response and its suppression should be balanced against the potential benefits it offers in fighting infection.
Close monitoring of patients with pyrexia is crucial. Persistent or recurrent fever despite treatment warrants further investigation. It may indicate an uncontrolled infection, drug fever, or non-infectious causes like malignancies or autoimmune diseases. Follow-up is essential to ensure resolution of the fever and the underlying cause.
Pyrexia is a common yet complex clinical symptom. Understanding its mechanisms, careful assessment, targeted management, and vigilant monitoring are key to effective patient care. As clinicians, we must continually update our knowledge and skills in managing pyrexia to improve patient outcomes.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation